终末期肝病合并感染诊治专家共识(2021年版)

Expert consensus on diagnosis and treatment of end-stage liver disease complicated with infection(2021 version)

终末期肝病(ESLD)发生和发展中,感染可以诱发或加重ESLD肝功能失代偿的发生,亦是ESLD发展过程中最易出现的并发症之一。ESLD合并感染的规范诊疗需求迫切,2018年7月,中华医学会感染病学分会制订了我国第一部《终末期肝病合并感染诊治专家共识》,基于2018年至今的循证医学数据及治疗方案,进行本次修订。本共识旨在指导并提高临床医务工作者对ESLD合并感染性疾病的综合诊治能力。

End-stage liver disease(ESLD)is a life-threatening clinical syndrome with significantly increased mortality when the patients are complicated with infections.For patients with ESLD,infections can induce or aggravate the liver decompensation.In turn,infections are among the most common complication with the disease progression.Experts from Society of Infectious Diseases,Chinese Medical Association firstly formulated"Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infection"in July 2018.The 2021 version was extensively revised based on clinical evidence of recent three years,which summarizes the up-to-date knowledge and experiences across Chinese colleagues,intending to provide principles and working procedures for clinicians to diagnose and treat ESLD patients complicated with infections.